ORENCIA sol inj 125 mg/ml sering pré-remp 4 x 1 ml
7680621410025
CH-62141
L04AA24
07.15.0.
Reimbursement limitations:
ORENCIAINJ
Le traitement avec Orencia exige une garantie préalable de prise en charge des frais par …
1 / 3
google
Details
- Product number
- 6214101
- CPT
- -
- Packaging group
- 4
- Unit
- Fertigspritze(n)
- Composition
- abataceptum 125 mg, saccharum, poloxamerum 188, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, aqua ad iniectabile ad solutionem pro 1 ml corresp. natrium 0.32 mg.
Articles (1)
Orencia, Injektionslösung zur subkutanen Anwendung (Fertigspritze mit Nadelschutz)
Injektionslösung zur subkutanen Anwendung (Fertigspritze mit Nadelschutz)
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
125.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.32 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 1044.75
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/05/2012
Authorization holder
Bristol-Myers Squibb SA
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 62141
- Drug name
- Orencia, Injektionslösung zur subkutanen Anwendung (Fertigspritze mit Nadelschutz)
- Galenic form
- INLFS
- ATC Code
- L04AA24
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 27/02/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ORENCIA sol inj 125 mg/ml sering pré-remp 4 x 1 ml
- Description (DE)
- ORENCIA Inj Lös 125 mg/ml Fertigspritze 4 x 1 ml
- Market launch
- 27/02/2012
- Narcotic (BTM)
- No